Strides Arcolab buys 70% in biotech start-up Inbiopro

10 Dec 2010 Evaluate

Strides Arcolab announced its entry into biologics, with the signing of an agreement to acquire 70 per cent stake in biotechnology company Inbiopro Solutions, based in Bangalore.

Inbiopro is a biotech outsourced research start-up and has eight candidate products in oncology to begin with. Strides will invest Rs 65 crore over three years in the form of growth capital to develop and commercialise the eight products. The acquisition gives Strides immediate access to a pipeline of eight products estimated to have global sales of over $28 billion. Commercialisation of these products is expected to begin in 2013.

Strides Pharma Scien Share Price

684.30 -15.00 (-2.15%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.